期刊文献+

鞭毛蛋白与IL-12协同诱导人NK细胞产生IFN-γ机制的探讨 被引量:2

The synergistic effect of flagellin and interleukine-12 on the induction of IFN-γ production from human NK cells and its mechanism
下载PDF
导出
摘要 目的:探讨细菌鞭毛蛋白(flagellin)与IL-12协同诱导人NK细胞产生IFN-γ的作用和机制。方法:自正常人静脉血中分离PBMCs,分别与培养液(medium)、flagellin、IL-12或flagellin+IL-12共同培养。三天后,利用酶联免疫吸附法(ELISA法)检测培养上清中IFN-γ的水平。收集初次培养组细胞,洗去刺激后进行二次培养,检测IFN-γ的产生。利用流式细胞仪检测NK细胞上IL-12Rβ1和TLR5的表达情况。结果:一次培养的结果表明,flagellin或IL-12单独刺激PBMCs可诱导较低水平IFN-γ的产生。共同刺激下,可协同诱导高水平IFN-γ产生。二次培养结果表明,不同剂量IL-12的刺激flagellin初次培养组细胞,IFN-γ的产生呈剂量依赖性的增加;IL-12初次刺激组细胞在flagellin的二次刺激下,IFN-γ的产生亦呈剂量依赖性增加。流式结果表明,flagellin可上调NK细胞IL-12Rβ1的表达。IL-12可上调NK细胞TLR5的表达。结论:flagellin通过上调NK细胞IL-12Rβ1的表达,IL-12通过促进NK细胞TLR5的表达,从而协同诱导IFN-γ的产生。 Objective:To study the synergic effect of flagellin and interleukine-12(IL-12) on the production of IFN-γ by human NK cells and its mechanism.Methods:PBMCs isolated from normal donors were cultured with medium,flagellin,IL-12 or flagellin plus IL-12.Culture supernatants were collected at day 3 and the level of IFN-γ was measured by ELISA.Cells under primary culture conditions were collected,washed,restimulated,and the production of IFN-γ was detected after 3 days.The expression of IL-12 receptor β1 and toll-like receptor 5 on NK cell subsets was detected and analyzed by flow cytometry.Results:In the primary culture conditions,application of suboptimal dose of flagellin or IL-12 could induce low levels of IFN-γ.Stimulation of PBMCs with flagellin plus IL-12 could synergistically induce IFN-γ production.Under the secondary culture conditions,cells that pre-treated with flagellin were restimulated with different concentrations of IL-12,which could induce high levels of IFN-γ in a dose-dependent manner.Cells pre-stimulated with IL-12 could,in a dose-dependent manner,enhance the production of IFN-γ in the presence of different concentrations of flagellin.Flow cytometry analysis indicated that the expression of IL-12 receptorβ1 on NK cell subsets was upregulated when stimulated with flagellin and IL-12 could enhance the expression of toll-like receptor 5 on NK cell subsets.Conclusion:Up-regulation of IL-12 receptorβ1 by flagellin and enhanced expression of the toll-like receptor 5 by IL-12 contribute to the synergistic effects of IFN-γ production by NK cell subsets.
出处 《中国免疫学杂志》 CAS CSCD 北大核心 2011年第4期303-307,共5页 Chinese Journal of Immunology
基金 教育部2007年度高等学校博士学科点专项科研基金(20070558213)项目
关键词 鞭毛 IL-12 NK细胞 IFN-Γ flagellin; Interleukine-12(IL-12); NK cells; Interferon-γ(IFN-γ)
  • 相关文献

参考文献10

  • 1Merlo A,Calcaterra C,Menard S et al.Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses[J].J Leukoc Biol,2007;82(3):509-518.
  • 2Liaudet L,Murthy K G,Mabley J G et al.Comparison of inflammation,organ damage,and oxidant stress induced by Salmonella enterica serovar Muenchen flagellin and serovar Enteritidis lipopolysaccharide[J].Infect Immun,2002;70(1):192-198.
  • 3刘昀,范艳莹,李丽,尹凌凡,杨滨燕,张宜俊,吴长有.绿脓杆菌制剂与IL-12在诱导人NK细胞IFN-γ产生中的协同作用[J].现代免疫学,2007,27(6):488-492. 被引量:22
  • 4Yun C H,Lundgren A,Azem J et al.Natural killer cells and Helicobacter pylori infection:bacterial antigens and interleukin-12 act synergistically to induce gamma interferon production[J].Infect Immun,2005;73(3):1482-1490.
  • 5Wu C,Ferrante J,Gately M K et al.Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice:IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor[J].J Immunol,1997;159(4):1658-1665.
  • 6van de Vosse E,Lichtenauer-Kaligis E G,van Dissel J T et al.Genetic variations in the interleukin-12/interleukin-23 receptor (beta1) chain,and implications for IL-12 and IL-23 receptor structure and function[J].Immunogenetics,2003;54(12):817-829.
  • 7尹凌凡,范艳莹,李丽,吴长有.Toll样配体(R-848)与IL-12对人NK细胞亚群IFN-γ产生的作用[J].细胞与分子免疫学杂志,2007,23(7):623-626. 被引量:9
  • 8Chalifour A,Jeannin P,Gauchat J F et al.Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production[J].Blood,2004;104(6):1778-1783.
  • 9Borges M M,Campos-Neto A,Sleath P et al.Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant protein[J].Infect Immun,2001;69(9):5270-5277.
  • 10Hayashi F,Smith K D,Ozinsky A et al.The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5[J].Nature,2001;410(6832):1099-1103.

二级参考文献22

共引文献28

同被引文献19

  • 1Meir Djaldetti,Hanna Bessler.Modulators affecting the immune dialogue between human immune and colon cancer cells[J].World Journal of Gastrointestinal Oncology,2014,6(5):129-138. 被引量:8
  • 2Joseph S, Sandra L, Charles C, et al. NK cells and immune "Memory"[J]. J Immunol,2011,186(7) : 1891-1897.
  • 3Andrea M,Federiea B,Claudia C,et al. Revisiting human natural killer cell subset function revealed cytolytic CD56dimCD16+ NK- cells as rapid producers of abundant IFN- on activation[J]. PNAS,2011,108(12) :728-732.
  • 4Tsan MF,Gao B. Heat shock proteins and immune system[J].J Leukoc Biol,2009,85(6) :905-910.
  • 5Rober GM, athias G, Maria A, et al. Heat shock protein 70 sur- face-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells[J]. Cancer Res,2005,65(8) : 5238-5245.
  • 6Robert G,Catharina G,lydia R, et al. The cell surface localized heat shock protein 70 epitope TKD induces migration and cyto- lyric activity selectively in human NK eells[J]. J Immunol, 2004, 172(9) :972-980.
  • 7Haddad EA,Senge LK,Takei F. An accessory role for B cells in the IL 12-induced activation of resting mouse NK cells[J]. JIm munol,2009,183(8) :3608-3615.
  • 8May S, Maria T, Ismail B, et al. Leukemic priming of resting NK cells Is killer Ig like receptor independent but requires CD15 me diated CD2 ligation and natural eytotoxicity reeeptors[J]. Immu- nol,2011,187(8) :6227-6234.
  • 9Stefan S, Mathias G, Julia R, et al. Targeting membrane heat shock protein 70 (HspT0) on tumors by cmHspT0. 1 antibody [J]. PNAS,2011,108(2) :733-738.
  • 10Stefan S,Krause W,Robert G,et al. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70 peptide-activa- ted autologous natural killer cells~ a clinical phase I trial[J]. Clin Cancer Res,2004,10(1):3699-3707.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部